EXEL PEER ANALYSIS

Exelixis Inc — metric-by-metric comparison with peers and the industry median

EXELExelixis Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

EXELIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	EXEL	CSL	TLX	MSB	Ind. Median
P/E	17.91●	29.44	—	—	17.91
P/B	7.71	2.20●	6.37	—	3.51
EV/EBITDA	14.11	10.21●	120.14	—	14.82
P/S	6.28	2.62●	3.24	31.61	10.89

Financial Health
Metric	EXEL	CSL	TLX	MSB	Ind. Median
Current Ratio	3.26●	2.57	1.43	—	5.90
Debt/Equity	8.8%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-0.60●	2.22	13.13	—	1.15

Profitability
Metric	EXEL	CSL	TLX	MSB	Ind. Median
Net Margin	35.1%●	9.2%	-0.9%	-115.3%	-125.7%
ROE	41.0%●	7.7%	-1.8%	-11.3%	-47.5%
ROA	30.7%●	3.8%	-0.7%	-8.6%	-35.8%
EBITDA Margin	42.7%●	32.8%	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	EXEL	CSL	TLX	MSB	Ind. Median
Rev. Growth	3.3%	4.8%	56.3%	410.4%●	5.1%
NI Growth	29.5%●	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	EXEL	BBIO	MDGL	JAZZ	IONS	AXSM	Ind. Median
P/E	17.91●	—	—	545.67	—	—	17.91
P/B	7.71	-6.63●	28.21	3.55	27.24	229.14	3.51
EV/EBITDA	14.11	—	—	34.25	2.95●	—	14.82
P/S	6.28	25.93	13.54	3.63●	12.65	17.66	10.89

Financial Health
Metric	EXEL	BBIO	MDGL	JAZZ	IONS	AXSM	Ind. Median
Current Ratio	3.26	1.44	3.50	2.04	4.10●	1.39	5.90
Debt/Equity	8.8%	-149.2%●	63.9%	119.5%	415.3%	402.8%	10.9%
NetDebt/EBITDA	-0.60	-4.02●	1.67	4.67	0.03	0.49	1.15

Profitability
Metric	EXEL	BBIO	MDGL	JAZZ	IONS	AXSM	Ind. Median
Net Margin	35.1%●	-125.2%	-27.3%	0.7%	-30.9%	-26.6%	-125.7%
ROE	41.0%●	—	-49.3%	0.7%	-67.5%	-349.4%	-47.5%
ROA	30.7%●	-64.5%	-27.8%	0.3%	-10.4%	-28.7%	-35.8%
EBITDA Margin	42.7%	-105.0%	-24.8%	12.3%	433.5%●	-24.4%	-105.8%

Growth + Dividend
Metric	EXEL	BBIO	MDGL	JAZZ	IONS	AXSM	Ind. Median
Rev. Growth	3.3%	355.2%●	256.8%	9.2%	47.5%	63.9%	5.1%
NI Growth	29.5%●	—	—	-93.9%	—	—	12.1%
Div. Yield	—	—	—	—	0.2%	—	0.2%
Payout	—	—	—	—	-6.7%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on EXEL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.